
Opinion|Videos|May 15, 2024
Payer Needs and Strategies for Evaluating and Covering PDTs
Panelists delve into the data and the cost-saving evidence required by payers to cover prescription digital therapeutics (PDTs), outline the decision-making process followed by payers, and share best practices observed in real-world to ensure the successful implementation of PDTs.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Diagnosing Alzheimer's Disease Agitation: Triggers, Care Specialties, and the Role of Primary Care
2
FDA Approves First Autoinjector for At-Home IV-Equivalent Diuresis
3
Defining Alzheimer's Disease Agitation: Diagnostic Criteria, Symptoms, and Disease Course
4
Small Workflow Changes Close Big Gaps in CKM Screening
5




